Placebo controlled phase ii trial to evaluate the safety. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Esophagogastric Junction

Diseases71

Lung Neoplasms Neoplasm Metastasis Neoplasm Recurrence, Local Neutropenia Carcinoma, Non-Small-Cell Lung Disease Progression Nausea Leukopenia Thrombocytopenia Neoplasms Adenocarcinoma Breast Neoplasms Brain Neoplasms Biliary Tract Neoplasms Kidney Neoplasms Vomiting Carcinoma, Renal Cell Colorectal Neoplasms Melanoma Hematologic Diseases Peritoneal Neoplasms Recurrence Ovarian Neoplasms Carcinoma, Squamous Cell Pancreatic Neoplasms Drug-Related Side Effects and Adverse Reactions Head and Neck Neoplasms Fatigue Prostatic Neoplasms Carcinoma, Small Cell Stomach Neoplasms Glioblastoma Diarrhea Carcinoma Pleural Neoplasms Urologic Neoplasms Exanthema Liver Neoplasms Sarcoma Bone Neoplasms Glioma Lymphoma, Non-Hodgkin Stomatitis Mesothelioma Vomiting, Anticipatory Carcinoma, Transitional Cell Asthenia Anemia Soft Tissue Neoplasms Anorexia Skin Neoplasms Esophageal Neoplasms Drug Eruptions Neoplasms, Glandular and Epithelial Gastrointestinal Diseases Neoplasms, Unknown Primary Pain Lymphoma, Follicular Rectal Neoplasms Oligodendroglioma Lymphoma, T-Cell, Cutaneous Gallbladder Neoplasms Small Cell Lung Carcinoma Peripheral Nervous System Diseases Bone Marrow Diseases Acute Disease Gastrointestinal Neoplasms Fallopian Tube Neoplasms Agranulocytosis Lymphoma, Mantle-Cell Urinary Bladder Neoplasms

Chemicals and Drugs93

Deoxycytidine Antineoplastic Agents Paclitaxel Taxoids Cisplatin Fluorouracil Antibodies, Monoclonal, Humanized Antineoplastic Agents, Phytogenic Carboplatin Camptothecin Organoplatinum Compounds Antimetabolites, Antineoplastic Dacarbazine Vinblastine Antibodies, Monoclonal Quinazolines Leucovorin Antineoplastic Agents, Alkylating Doxorubicin Benzenesulfonates Tegafur Epothilones Etoposide Phenylurea Compounds Oxonic Acid Niacinamide Ifosfamide Estramustine Thalidomide Angiogenesis Inhibitors Cyclophosphamide Guanine Placebos Drug Combinations Pyridines Antibodies, Monoclonal, Murine-Derived Epirubicin Vincristine Pyrroles Protein Kinase Inhibitors Interferon-alpha Glutamates Pyrazines Mesna Prostate-Specific Antigen Antibiotics, Antineoplastic Topotecan Granulocyte Colony-Stimulating Factor Recombinant Proteins Boronic Acids Pyrimidines Anthracyclines Tumor Markers, Biological Mitoxantrone Vidarabine Phosphate Platinum Compounds Prednisone Bridged Compounds Nitrogen Mustard Compounds Drugs, Investigational Biomarkers, Pharmacological Indoles Benzamides Piperazines Cancer Vaccines Dexamethasone Receptor, Epidermal Growth Factor Sulfonamides Depsipeptides Thiophenes Piperidines Pyrazoles Receptor, erbB-2 Uracil Bryostatins Sirolimus Methotrexate Isotretinoin Polyethylene Glycols Carmustine Mitomycin Antineoplastic Agents, Hormonal Mitotane Thymus Extracts Interleukin-2 Quinolines Triazoles Cytarabine Melphalan Platinum Lactones Immunologic Factors Cladribine

Analytical, Diagnostic and Therapeutic Techniques and Equipment72

Clinical Trials, Phase II as Topic Treatment Outcome Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Clinical Trials as Topic Double-Blind Method Infusions, Intravenous Drug Evaluation Disease-Free Survival Survival Analysis Survival Rate Administration, Oral Clinical Trials, Phase III as Topic Combined Modality Therapy Maximum Tolerated Dose Neoplasm Staging Research Design Salvage Therapy Clinical Trials, Phase I as Topic Kaplan-Meier Estimate Follow-Up Studies Remission Induction Prospective Studies Neoadjuvant Therapy Endpoint Determination Feasibility Studies Early Termination of Clinical Trials Chemotherapy, Adjuvant Randomized Controlled Trials as Topic Drug Therapy, Combination Treatment Failure Placebos Prognosis Patient Selection Cross-Over Studies Multicenter Studies as Topic Sample Size Injections, Subcutaneous Pilot Projects Injections, Intravenous Dose Fractionation Single-Blind Method Area Under Curve Karnofsky Performance Status Chemoradiotherapy Controlled Clinical Trials as Topic Radiotherapy, Adjuvant Induction Chemotherapy Clinical Protocols Severity of Illness Index Equipment Safety Risk Assessment Radiotherapy Dosage Administration, Intravenous Infusions, Parenteral Radioimmunotherapy Premedication Palliative Care Radiotherapy Immunotherapy Risk Factors Probability Pain Measurement Analysis of Variance Retreatment Drug Approval Molecular Targeted Therapy Confidence Intervals Transplantation, Autologous Cohort Studies Retrospective Studies Metabolic Clearance Rate

Psychiatry and Psychology2

Pain Patient Compliance

Phenomena and Processes9

Dose-Response Relationship, Drug Maximum Tolerated Dose Time Factors Metabolic Detoxication, Phase II Drug Resistance, Neoplasm Area Under Curve Pain Probability Metabolic Clearance Rate

Disciplines and Occupations2

Research Design Medical Oncology

Anthropology, Education, Sociology and Social Phenomena3

Quality of Life Survival Drug Approval

Technology, Industry, Agriculture2

Food Safety Polyethylene Glycols

Humanities1

Quality of Life

Information Science1

Health Care42

Clinical Trials, Phase II as Topic Treatment Outcome Safety Clinical Trials as Topic Double-Blind Method Disease-Free Survival Placebo Effect Survival Analysis Survival Rate Clinical Trials, Phase III as Topic Clinical Trials, Phase I as Topic Kaplan-Meier Estimate Safety Management Follow-Up Studies Prospective Studies Patient Safety Feasibility Studies Early Termination of Clinical Trials Randomized Controlled Trials as Topic Treatment Failure Patient Selection Cross-Over Studies Multicenter Studies as Topic Sample Size Pilot Projects Single-Blind Method Area Under Curve Karnofsky Performance Status Controlled Clinical Trials as Topic Food Safety Clinical Protocols Severity of Illness Index Risk Assessment Palliative Care Consumer Product Safety Risk Factors Probability Analysis of Variance Patient Compliance Confidence Intervals Cohort Studies Retrospective Studies

Geographicals1

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Health Care Geographicals

Clinical Trials, Phase II as Topic Treatment Outcome Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Safety Clinical Trials as Topic Double-Blind Method Infusions, Intravenous Deoxycytidine Antineoplastic Agents Drug Evaluation Disease-Free Survival Paclitaxel Placebo Effect Survival Analysis Taxoids Cisplatin Fluorouracil Survival Rate Lung Neoplasms Antibodies, Monoclonal, Humanized Administration, Oral Clinical Trials, Phase III as Topic Antineoplastic Agents, Phytogenic Combined Modality Therapy Carboplatin Neoplasm Metastasis Neoplasm Recurrence, Local Dose-Response Relationship, Drug Camptothecin Neutropenia Organoplatinum Compounds Antimetabolites, Antineoplastic Maximum Tolerated Dose Carcinoma, Non-Small-Cell Lung Neoplasm Staging Research Design Salvage Therapy Disease Progression Clinical Trials, Phase I as Topic Dacarbazine Vinblastine Nausea Leukopenia Antibodies, Monoclonal Quinazolines Time Factors Kaplan-Meier Estimate Leucovorin Safety Management Follow-Up Studies Metabolic Detoxication, Phase II Remission Induction Prospective Studies Thrombocytopenia Neoplasms Adenocarcinoma Antineoplastic Agents, Alkylating Doxorubicin Benzenesulfonates Patient Safety Tegafur Neoadjuvant Therapy Endpoint Determination Epothilones Breast Neoplasms Etoposide Phenylurea Compounds Oxonic Acid Niacinamide Brain Neoplasms Biliary Tract Neoplasms Ifosfamide Feasibility Studies Drug Resistance, Neoplasm Kidney Neoplasms Estramustine Vomiting Thalidomide Carcinoma, Renal Cell Early Termination of Clinical Trials Chemotherapy, Adjuvant Randomized Controlled Trials as Topic Colorectal Neoplasms Melanoma Hematologic Diseases Drug Therapy, Combination Peritoneal Neoplasms Angiogenesis Inhibitors Recurrence Treatment Failure Cyclophosphamide Ovarian Neoplasms Carcinoma, Squamous Cell Guanine Placebos Quality of Life Drug Combinations Prognosis Patient Selection

No FAQ available that match "placebo controlled phase ii trial to evaluate the safety"